nodes	percent_of_prediction	percent_of_DWPC	metapath
Bupivacaine—CYP3A4—Thiotepa—urinary bladder cancer	0.055	0.347	CbGbCtD
Bupivacaine—CYP1A2—Fluorouracil—urinary bladder cancer	0.0341	0.215	CbGbCtD
Bupivacaine—CYP1A2—Etoposide—urinary bladder cancer	0.0285	0.179	CbGbCtD
Bupivacaine—CYP2D6—Doxorubicin—urinary bladder cancer	0.016	0.101	CbGbCtD
Bupivacaine—CYP3A4—Etoposide—urinary bladder cancer	0.0149	0.094	CbGbCtD
Bupivacaine—CYP2C19—urine—urinary bladder cancer	0.0113	0.146	CbGeAlD
Bupivacaine—CYP3A4—Doxorubicin—urinary bladder cancer	0.0102	0.0641	CbGbCtD
Bupivacaine—PTGER1—renal system—urinary bladder cancer	0.0097	0.126	CbGeAlD
Bupivacaine—CYP1A2—urine—urinary bladder cancer	0.00922	0.12	CbGeAlD
Bupivacaine—SCN4A—prostate gland—urinary bladder cancer	0.0081	0.105	CbGeAlD
Bupivacaine—PTGER1—female reproductive system—urinary bladder cancer	0.00776	0.101	CbGeAlD
Bupivacaine—CYP3A4—urine—urinary bladder cancer	0.00667	0.0865	CbGeAlD
Bupivacaine—CYP2D6—urine—urinary bladder cancer	0.00656	0.0851	CbGeAlD
Bupivacaine—SCN4A—renal system—urinary bladder cancer	0.00552	0.0716	CbGeAlD
Bupivacaine—CYP1A2—renal system—urinary bladder cancer	0.00225	0.0292	CbGeAlD
Bupivacaine—SCN10A—lymph node—urinary bladder cancer	0.00221	0.0286	CbGeAlD
Bupivacaine—Lidocaine—EGFR—urinary bladder cancer	0.002	1	CrCbGaD
Bupivacaine—CYP2C19—vagina—urinary bladder cancer	0.002	0.0259	CbGeAlD
Bupivacaine—CYP3A4—renal system—urinary bladder cancer	0.00163	0.0212	CbGeAlD
Bupivacaine—CYP2D6—renal system—urinary bladder cancer	0.00161	0.0208	CbGeAlD
Bupivacaine—CYP3A4—female reproductive system—urinary bladder cancer	0.00131	0.017	CbGeAlD
Bupivacaine—CYP2D6—female reproductive system—urinary bladder cancer	0.00129	0.0167	CbGeAlD
Bupivacaine—Pruritus—Thiotepa—urinary bladder cancer	0.000542	0.000874	CcSEcCtD
Bupivacaine—Pain—Fluorouracil—urinary bladder cancer	0.000542	0.000874	CcSEcCtD
Bupivacaine—Paraesthesia—Cisplatin—urinary bladder cancer	0.000539	0.00087	CcSEcCtD
Bupivacaine—Tachycardia—Etoposide—urinary bladder cancer	0.000537	0.000866	CcSEcCtD
Bupivacaine—Dyspnoea—Cisplatin—urinary bladder cancer	0.000536	0.000864	CcSEcCtD
Bupivacaine—Skin disorder—Etoposide—urinary bladder cancer	0.000535	0.000862	CcSEcCtD
Bupivacaine—Hyperhidrosis—Etoposide—urinary bladder cancer	0.000532	0.000858	CcSEcCtD
Bupivacaine—Feeling abnormal—Gemcitabine—urinary bladder cancer	0.000531	0.000857	CcSEcCtD
Bupivacaine—Orthostatic hypotension—Doxorubicin—urinary bladder cancer	0.000531	0.000855	CcSEcCtD
Bupivacaine—Diarrhoea—Thiotepa—urinary bladder cancer	0.000524	0.000845	CcSEcCtD
Bupivacaine—Aspartate aminotransferase increased—Doxorubicin—urinary bladder cancer	0.000523	0.000843	CcSEcCtD
Bupivacaine—Decreased appetite—Cisplatin—urinary bladder cancer	0.000522	0.000842	CcSEcCtD
Bupivacaine—Feeling abnormal—Fluorouracil—urinary bladder cancer	0.000522	0.000842	CcSEcCtD
Bupivacaine—Gastrointestinal disorder—Cisplatin—urinary bladder cancer	0.000519	0.000836	CcSEcCtD
Bupivacaine—Infestation—Methotrexate—urinary bladder cancer	0.000517	0.000834	CcSEcCtD
Bupivacaine—Infestation NOS—Methotrexate—urinary bladder cancer	0.000517	0.000834	CcSEcCtD
Bupivacaine—Drowsiness—Methotrexate—urinary bladder cancer	0.000517	0.000834	CcSEcCtD
Bupivacaine—Hypotension—Etoposide—urinary bladder cancer	0.000514	0.000829	CcSEcCtD
Bupivacaine—Pain—Cisplatin—urinary bladder cancer	0.000514	0.000828	CcSEcCtD
Bupivacaine—Muscular weakness—Doxorubicin—urinary bladder cancer	0.000512	0.000826	CcSEcCtD
Bupivacaine—Alanine aminotransferase increased—Doxorubicin—urinary bladder cancer	0.000512	0.000826	CcSEcCtD
Bupivacaine—Body temperature increased—Gemcitabine—urinary bladder cancer	0.00051	0.000822	CcSEcCtD
Bupivacaine—Dizziness—Thiotepa—urinary bladder cancer	0.000507	0.000817	CcSEcCtD
Bupivacaine—Abdominal distension—Doxorubicin—urinary bladder cancer	0.000505	0.000815	CcSEcCtD
Bupivacaine—Urticaria—Fluorouracil—urinary bladder cancer	0.000503	0.000812	CcSEcCtD
Bupivacaine—Dysphagia—Doxorubicin—urinary bladder cancer	0.000502	0.00081	CcSEcCtD
Bupivacaine—Body temperature increased—Fluorouracil—urinary bladder cancer	0.000501	0.000808	CcSEcCtD
Bupivacaine—Sweating—Methotrexate—urinary bladder cancer	0.000496	0.000799	CcSEcCtD
Bupivacaine—Feeling abnormal—Cisplatin—urinary bladder cancer	0.000495	0.000798	CcSEcCtD
Bupivacaine—Paraesthesia—Etoposide—urinary bladder cancer	0.000494	0.000797	CcSEcCtD
Bupivacaine—Haematuria—Methotrexate—urinary bladder cancer	0.000493	0.000795	CcSEcCtD
Bupivacaine—Dyspnoea—Etoposide—urinary bladder cancer	0.000491	0.000791	CcSEcCtD
Bupivacaine—Somnolence—Etoposide—urinary bladder cancer	0.000489	0.000789	CcSEcCtD
Bupivacaine—Vomiting—Thiotepa—urinary bladder cancer	0.000487	0.000786	CcSEcCtD
Bupivacaine—Infestation NOS—Epirubicin—urinary bladder cancer	0.000484	0.00078	CcSEcCtD
Bupivacaine—Infestation—Epirubicin—urinary bladder cancer	0.000484	0.00078	CcSEcCtD
Bupivacaine—Drowsiness—Epirubicin—urinary bladder cancer	0.000484	0.00078	CcSEcCtD
Bupivacaine—Headache—Thiotepa—urinary bladder cancer	0.00048	0.000774	CcSEcCtD
Bupivacaine—Decreased appetite—Etoposide—urinary bladder cancer	0.000478	0.000772	CcSEcCtD
Bupivacaine—Gastrointestinal disorder—Etoposide—urinary bladder cancer	0.000475	0.000766	CcSEcCtD
Bupivacaine—Body temperature increased—Cisplatin—urinary bladder cancer	0.000475	0.000766	CcSEcCtD
Bupivacaine—Neuropathy peripheral—Epirubicin—urinary bladder cancer	0.000474	0.000765	CcSEcCtD
Bupivacaine—Pain—Etoposide—urinary bladder cancer	0.000471	0.000759	CcSEcCtD
Bupivacaine—Constipation—Etoposide—urinary bladder cancer	0.000471	0.000759	CcSEcCtD
Bupivacaine—Urinary tract infection—Epirubicin—urinary bladder cancer	0.00047	0.000758	CcSEcCtD
Bupivacaine—Hypersensitivity—Fluorouracil—urinary bladder cancer	0.000467	0.000753	CcSEcCtD
Bupivacaine—Sweating—Epirubicin—urinary bladder cancer	0.000464	0.000748	CcSEcCtD
Bupivacaine—Asthenia—Gemcitabine—urinary bladder cancer	0.000462	0.000746	CcSEcCtD
Bupivacaine—Haematuria—Epirubicin—urinary bladder cancer	0.000461	0.000744	CcSEcCtD
Bupivacaine—Pruritus—Gemcitabine—urinary bladder cancer	0.000456	0.000735	CcSEcCtD
Bupivacaine—Nausea—Thiotepa—urinary bladder cancer	0.000455	0.000734	CcSEcCtD
Bupivacaine—Feeling abnormal—Etoposide—urinary bladder cancer	0.000454	0.000731	CcSEcCtD
Bupivacaine—Gastrointestinal pain—Etoposide—urinary bladder cancer	0.00045	0.000726	CcSEcCtD
Bupivacaine—Pruritus—Fluorouracil—urinary bladder cancer	0.000448	0.000723	CcSEcCtD
Bupivacaine—Infestation NOS—Doxorubicin—urinary bladder cancer	0.000448	0.000722	CcSEcCtD
Bupivacaine—Drowsiness—Doxorubicin—urinary bladder cancer	0.000448	0.000722	CcSEcCtD
Bupivacaine—Infestation—Doxorubicin—urinary bladder cancer	0.000448	0.000722	CcSEcCtD
Bupivacaine—Hypersensitivity—Cisplatin—urinary bladder cancer	0.000443	0.000714	CcSEcCtD
Bupivacaine—Bradycardia—Epirubicin—urinary bladder cancer	0.000442	0.000713	CcSEcCtD
Bupivacaine—Diarrhoea—Gemcitabine—urinary bladder cancer	0.000441	0.000711	CcSEcCtD
Bupivacaine—Neuropathy peripheral—Doxorubicin—urinary bladder cancer	0.000439	0.000708	CcSEcCtD
Bupivacaine—Urticaria—Etoposide—urinary bladder cancer	0.000437	0.000705	CcSEcCtD
Bupivacaine—Body temperature increased—Etoposide—urinary bladder cancer	0.000435	0.000702	CcSEcCtD
Bupivacaine—Abdominal pain—Etoposide—urinary bladder cancer	0.000435	0.000702	CcSEcCtD
Bupivacaine—Urinary tract infection—Doxorubicin—urinary bladder cancer	0.000435	0.000702	CcSEcCtD
Bupivacaine—Diarrhoea—Fluorouracil—urinary bladder cancer	0.000434	0.000699	CcSEcCtD
Bupivacaine—Tinnitus—Methotrexate—urinary bladder cancer	0.000433	0.000698	CcSEcCtD
Bupivacaine—Hypoaesthesia—Epirubicin—urinary bladder cancer	0.000432	0.000697	CcSEcCtD
Bupivacaine—Asthenia—Cisplatin—urinary bladder cancer	0.000431	0.000695	CcSEcCtD
Bupivacaine—Cardiac disorder—Methotrexate—urinary bladder cancer	0.000431	0.000694	CcSEcCtD
Bupivacaine—Sweating—Doxorubicin—urinary bladder cancer	0.000429	0.000692	CcSEcCtD
Bupivacaine—Oedema peripheral—Epirubicin—urinary bladder cancer	0.000428	0.00069	CcSEcCtD
Bupivacaine—Haematuria—Doxorubicin—urinary bladder cancer	0.000427	0.000688	CcSEcCtD
Bupivacaine—Dizziness—Fluorouracil—urinary bladder cancer	0.000419	0.000676	CcSEcCtD
Bupivacaine—Chills—Methotrexate—urinary bladder cancer	0.000416	0.000671	CcSEcCtD
Bupivacaine—Diarrhoea—Cisplatin—urinary bladder cancer	0.000411	0.000663	CcSEcCtD
Bupivacaine—Vomiting—Gemcitabine—urinary bladder cancer	0.00041	0.000661	CcSEcCtD
Bupivacaine—Bradycardia—Doxorubicin—urinary bladder cancer	0.000409	0.00066	CcSEcCtD
Bupivacaine—Mental disorder—Methotrexate—urinary bladder cancer	0.000407	0.000656	CcSEcCtD
Bupivacaine—Hypersensitivity—Etoposide—urinary bladder cancer	0.000406	0.000654	CcSEcCtD
Bupivacaine—Tinnitus—Epirubicin—urinary bladder cancer	0.000405	0.000653	CcSEcCtD
Bupivacaine—Malnutrition—Methotrexate—urinary bladder cancer	0.000404	0.000651	CcSEcCtD
Bupivacaine—Erythema—Methotrexate—urinary bladder cancer	0.000404	0.000651	CcSEcCtD
Bupivacaine—Headache—Gemcitabine—urinary bladder cancer	0.000404	0.000651	CcSEcCtD
Bupivacaine—Flushing—Epirubicin—urinary bladder cancer	0.000403	0.00065	CcSEcCtD
Bupivacaine—Cardiac disorder—Epirubicin—urinary bladder cancer	0.000403	0.00065	CcSEcCtD
Bupivacaine—Vomiting—Fluorouracil—urinary bladder cancer	0.000403	0.00065	CcSEcCtD
Bupivacaine—Hypoaesthesia—Doxorubicin—urinary bladder cancer	0.0004	0.000645	CcSEcCtD
Bupivacaine—Headache—Fluorouracil—urinary bladder cancer	0.000397	0.00064	CcSEcCtD
Bupivacaine—Oedema peripheral—Doxorubicin—urinary bladder cancer	0.000396	0.000638	CcSEcCtD
Bupivacaine—Asthenia—Etoposide—urinary bladder cancer	0.000395	0.000637	CcSEcCtD
Bupivacaine—Back pain—Methotrexate—urinary bladder cancer	0.000391	0.00063	CcSEcCtD
Bupivacaine—Chills—Epirubicin—urinary bladder cancer	0.00039	0.000628	CcSEcCtD
Bupivacaine—Pruritus—Etoposide—urinary bladder cancer	0.000389	0.000628	CcSEcCtD
Bupivacaine—Arrhythmia—Epirubicin—urinary bladder cancer	0.000388	0.000626	CcSEcCtD
Bupivacaine—Nausea—Gemcitabine—urinary bladder cancer	0.000383	0.000617	CcSEcCtD
Bupivacaine—Vomiting—Cisplatin—urinary bladder cancer	0.000382	0.000616	CcSEcCtD
Bupivacaine—Vision blurred—Methotrexate—urinary bladder cancer	0.000381	0.000614	CcSEcCtD
Bupivacaine—Mental disorder—Epirubicin—urinary bladder cancer	0.00038	0.000614	CcSEcCtD
Bupivacaine—Malnutrition—Epirubicin—urinary bladder cancer	0.000378	0.00061	CcSEcCtD
Bupivacaine—Erythema—Epirubicin—urinary bladder cancer	0.000378	0.00061	CcSEcCtD
Bupivacaine—Diarrhoea—Etoposide—urinary bladder cancer	0.000377	0.000607	CcSEcCtD
Bupivacaine—Nausea—Fluorouracil—urinary bladder cancer	0.000376	0.000607	CcSEcCtD
Bupivacaine—Tinnitus—Doxorubicin—urinary bladder cancer	0.000375	0.000604	CcSEcCtD
Bupivacaine—Anaemia—Methotrexate—urinary bladder cancer	0.000373	0.000602	CcSEcCtD
Bupivacaine—Cardiac disorder—Doxorubicin—urinary bladder cancer	0.000373	0.000601	CcSEcCtD
Bupivacaine—Flushing—Doxorubicin—urinary bladder cancer	0.000373	0.000601	CcSEcCtD
Bupivacaine—Flatulence—Epirubicin—urinary bladder cancer	0.000373	0.000601	CcSEcCtD
Bupivacaine—Tension—Epirubicin—urinary bladder cancer	0.000371	0.000598	CcSEcCtD
Bupivacaine—Nervousness—Epirubicin—urinary bladder cancer	0.000367	0.000592	CcSEcCtD
Bupivacaine—Back pain—Epirubicin—urinary bladder cancer	0.000366	0.00059	CcSEcCtD
Bupivacaine—Dizziness—Etoposide—urinary bladder cancer	0.000364	0.000587	CcSEcCtD
Bupivacaine—Muscle spasms—Epirubicin—urinary bladder cancer	0.000363	0.000586	CcSEcCtD
Bupivacaine—Chills—Doxorubicin—urinary bladder cancer	0.000361	0.000581	CcSEcCtD
Bupivacaine—Arrhythmia—Doxorubicin—urinary bladder cancer	0.000359	0.000579	CcSEcCtD
Bupivacaine—Nausea—Cisplatin—urinary bladder cancer	0.000357	0.000575	CcSEcCtD
Bupivacaine—Vision blurred—Epirubicin—urinary bladder cancer	0.000356	0.000575	CcSEcCtD
Bupivacaine—Cough—Methotrexate—urinary bladder cancer	0.000353	0.000568	CcSEcCtD
Bupivacaine—Mental disorder—Doxorubicin—urinary bladder cancer	0.000352	0.000568	CcSEcCtD
Bupivacaine—Convulsion—Methotrexate—urinary bladder cancer	0.00035	0.000564	CcSEcCtD
Bupivacaine—Vomiting—Etoposide—urinary bladder cancer	0.00035	0.000564	CcSEcCtD
Bupivacaine—Erythema—Doxorubicin—urinary bladder cancer	0.00035	0.000564	CcSEcCtD
Bupivacaine—Malnutrition—Doxorubicin—urinary bladder cancer	0.00035	0.000564	CcSEcCtD
Bupivacaine—Anaemia—Epirubicin—urinary bladder cancer	0.000349	0.000563	CcSEcCtD
Bupivacaine—Agitation—Epirubicin—urinary bladder cancer	0.000347	0.00056	CcSEcCtD
Bupivacaine—Headache—Etoposide—urinary bladder cancer	0.000345	0.000556	CcSEcCtD
Bupivacaine—Flatulence—Doxorubicin—urinary bladder cancer	0.000345	0.000556	CcSEcCtD
Bupivacaine—Arthralgia—Methotrexate—urinary bladder cancer	0.000344	0.000555	CcSEcCtD
Bupivacaine—Tension—Doxorubicin—urinary bladder cancer	0.000343	0.000554	CcSEcCtD
Bupivacaine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—urinary bladder cancer	0.000342	0.000551	CcSEcCtD
Bupivacaine—Nervousness—Doxorubicin—urinary bladder cancer	0.00034	0.000548	CcSEcCtD
Bupivacaine—Syncope—Epirubicin—urinary bladder cancer	0.000339	0.000547	CcSEcCtD
Bupivacaine—Back pain—Doxorubicin—urinary bladder cancer	0.000338	0.000546	CcSEcCtD
Bupivacaine—Muscle spasms—Doxorubicin—urinary bladder cancer	0.000336	0.000542	CcSEcCtD
Bupivacaine—Palpitations—Epirubicin—urinary bladder cancer	0.000334	0.000539	CcSEcCtD
Bupivacaine—Confusional state—Methotrexate—urinary bladder cancer	0.000332	0.000536	CcSEcCtD
Bupivacaine—Loss of consciousness—Epirubicin—urinary bladder cancer	0.000332	0.000536	CcSEcCtD
Bupivacaine—Cough—Epirubicin—urinary bladder cancer	0.00033	0.000532	CcSEcCtD
Bupivacaine—Anaphylactic shock—Methotrexate—urinary bladder cancer	0.00033	0.000532	CcSEcCtD
Bupivacaine—Vision blurred—Doxorubicin—urinary bladder cancer	0.00033	0.000532	CcSEcCtD
Bupivacaine—Convulsion—Epirubicin—urinary bladder cancer	0.000328	0.000528	CcSEcCtD
Bupivacaine—Infection—Methotrexate—urinary bladder cancer	0.000328	0.000528	CcSEcCtD
Bupivacaine—Nausea—Etoposide—urinary bladder cancer	0.000327	0.000527	CcSEcCtD
Bupivacaine—Hypertension—Epirubicin—urinary bladder cancer	0.000326	0.000526	CcSEcCtD
Bupivacaine—Nervous system disorder—Methotrexate—urinary bladder cancer	0.000323	0.000521	CcSEcCtD
Bupivacaine—Anaemia—Doxorubicin—urinary bladder cancer	0.000323	0.000521	CcSEcCtD
Bupivacaine—Arthralgia—Epirubicin—urinary bladder cancer	0.000322	0.000519	CcSEcCtD
Bupivacaine—Agitation—Doxorubicin—urinary bladder cancer	0.000321	0.000518	CcSEcCtD
Bupivacaine—Anxiety—Epirubicin—urinary bladder cancer	0.000321	0.000517	CcSEcCtD
Bupivacaine—Skin disorder—Methotrexate—urinary bladder cancer	0.00032	0.000516	CcSEcCtD
Bupivacaine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—urinary bladder cancer	0.00032	0.000515	CcSEcCtD
Bupivacaine—Hyperhidrosis—Methotrexate—urinary bladder cancer	0.000319	0.000514	CcSEcCtD
Bupivacaine—Syncope—Doxorubicin—urinary bladder cancer	0.000314	0.000506	CcSEcCtD
Bupivacaine—Confusional state—Epirubicin—urinary bladder cancer	0.000311	0.000502	CcSEcCtD
Bupivacaine—CYP1A2—Aryl Hydrocarbon Receptor—ESR1—urinary bladder cancer	0.00031	0.00218	CbGpPWpGaD
Bupivacaine—Palpitations—Doxorubicin—urinary bladder cancer	0.000309	0.000498	CcSEcCtD
Bupivacaine—Anaphylactic shock—Epirubicin—urinary bladder cancer	0.000309	0.000498	CcSEcCtD
Bupivacaine—Oedema—Epirubicin—urinary bladder cancer	0.000309	0.000498	CcSEcCtD
Bupivacaine—Hypotension—Methotrexate—urinary bladder cancer	0.000308	0.000497	CcSEcCtD
Bupivacaine—Loss of consciousness—Doxorubicin—urinary bladder cancer	0.000307	0.000496	CcSEcCtD
Bupivacaine—Infection—Epirubicin—urinary bladder cancer	0.000307	0.000494	CcSEcCtD
Bupivacaine—Cough—Doxorubicin—urinary bladder cancer	0.000305	0.000492	CcSEcCtD
Bupivacaine—Shock—Epirubicin—urinary bladder cancer	0.000304	0.000489	CcSEcCtD
Bupivacaine—Convulsion—Doxorubicin—urinary bladder cancer	0.000303	0.000489	CcSEcCtD
Bupivacaine—Nervous system disorder—Epirubicin—urinary bladder cancer	0.000303	0.000488	CcSEcCtD
Bupivacaine—Hypertension—Doxorubicin—urinary bladder cancer	0.000302	0.000487	CcSEcCtD
Bupivacaine—Tachycardia—Epirubicin—urinary bladder cancer	0.000301	0.000486	CcSEcCtD
Bupivacaine—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	0.0003	0.000484	CcSEcCtD
Bupivacaine—Skin disorder—Epirubicin—urinary bladder cancer	0.0003	0.000483	CcSEcCtD
Bupivacaine—Hyperhidrosis—Epirubicin—urinary bladder cancer	0.000298	0.000481	CcSEcCtD
Bupivacaine—Insomnia—Methotrexate—urinary bladder cancer	0.000298	0.000481	CcSEcCtD
Bupivacaine—Arthralgia—Doxorubicin—urinary bladder cancer	0.000298	0.00048	CcSEcCtD
Bupivacaine—Anxiety—Doxorubicin—urinary bladder cancer	0.000297	0.000479	CcSEcCtD
Bupivacaine—Paraesthesia—Methotrexate—urinary bladder cancer	0.000296	0.000477	CcSEcCtD
Bupivacaine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—urinary bladder cancer	0.000296	0.000477	CcSEcCtD
Bupivacaine—Dyspnoea—Methotrexate—urinary bladder cancer	0.000294	0.000474	CcSEcCtD
Bupivacaine—Somnolence—Methotrexate—urinary bladder cancer	0.000293	0.000473	CcSEcCtD
Bupivacaine—Dyspepsia—Methotrexate—urinary bladder cancer	0.00029	0.000468	CcSEcCtD
Bupivacaine—Hypotension—Epirubicin—urinary bladder cancer	0.000288	0.000465	CcSEcCtD
Bupivacaine—SCN4A—Axon guidance—RHOA—urinary bladder cancer	0.000288	0.00203	CbGpPWpGaD
Bupivacaine—Confusional state—Doxorubicin—urinary bladder cancer	0.000288	0.000464	CcSEcCtD
Bupivacaine—Decreased appetite—Methotrexate—urinary bladder cancer	0.000287	0.000462	CcSEcCtD
Bupivacaine—Oedema—Doxorubicin—urinary bladder cancer	0.000285	0.00046	CcSEcCtD
Bupivacaine—Anaphylactic shock—Doxorubicin—urinary bladder cancer	0.000285	0.00046	CcSEcCtD
Bupivacaine—CYP2C19—Biological oxidations—HPGDS—urinary bladder cancer	0.000285	0.00201	CbGpPWpGaD
Bupivacaine—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	0.000285	0.000459	CcSEcCtD
Bupivacaine—Infection—Doxorubicin—urinary bladder cancer	0.000284	0.000457	CcSEcCtD
Bupivacaine—Pain—Methotrexate—urinary bladder cancer	0.000282	0.000455	CcSEcCtD
Bupivacaine—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	0.000281	0.000453	CcSEcCtD
Bupivacaine—Shock—Doxorubicin—urinary bladder cancer	0.000281	0.000453	CcSEcCtD
Bupivacaine—Nervous system disorder—Doxorubicin—urinary bladder cancer	0.00028	0.000451	CcSEcCtD
Bupivacaine—Insomnia—Epirubicin—urinary bladder cancer	0.000279	0.00045	CcSEcCtD
Bupivacaine—Tachycardia—Doxorubicin—urinary bladder cancer	0.000279	0.000449	CcSEcCtD
Bupivacaine—PTGER1—Signaling Pathways—HDAC4—urinary bladder cancer	0.000278	0.00196	CbGpPWpGaD
Bupivacaine—CYP1A2—Biological oxidations—NAT2—urinary bladder cancer	0.000278	0.00196	CbGpPWpGaD
Bupivacaine—SCN10A—Axon guidance—RHOA—urinary bladder cancer	0.000278	0.00196	CbGpPWpGaD
Bupivacaine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—urinary bladder cancer	0.000278	0.00196	CbGpPWpGaD
Bupivacaine—Skin disorder—Doxorubicin—urinary bladder cancer	0.000277	0.000447	CcSEcCtD
Bupivacaine—Paraesthesia—Epirubicin—urinary bladder cancer	0.000277	0.000447	CcSEcCtD
Bupivacaine—CYP2C19—Biological oxidations—GSTT1—urinary bladder cancer	0.000277	0.00195	CbGpPWpGaD
Bupivacaine—Hyperhidrosis—Doxorubicin—urinary bladder cancer	0.000276	0.000445	CcSEcCtD
Bupivacaine—Dyspnoea—Epirubicin—urinary bladder cancer	0.000275	0.000444	CcSEcCtD
Bupivacaine—CYP1A2—Metapathway biotransformation—NAT2—urinary bladder cancer	0.000274	0.00193	CbGpPWpGaD
Bupivacaine—Somnolence—Epirubicin—urinary bladder cancer	0.000274	0.000442	CcSEcCtD
Bupivacaine—Feeling abnormal—Methotrexate—urinary bladder cancer	0.000272	0.000438	CcSEcCtD
Bupivacaine—Dyspepsia—Epirubicin—urinary bladder cancer	0.000272	0.000438	CcSEcCtD
Bupivacaine—CYP1A2—Aryl Hydrocarbon Receptor—RB1—urinary bladder cancer	0.000271	0.0019	CbGpPWpGaD
Bupivacaine—Gastrointestinal pain—Methotrexate—urinary bladder cancer	0.00027	0.000435	CcSEcCtD
Bupivacaine—Decreased appetite—Epirubicin—urinary bladder cancer	0.000268	0.000432	CcSEcCtD
Bupivacaine—CYP2C19—Arachidonic acid metabolism—PTGS2—urinary bladder cancer	0.000267	0.00188	CbGpPWpGaD
Bupivacaine—SCN4A—Axon guidance—ERBB2—urinary bladder cancer	0.000267	0.00188	CbGpPWpGaD
Bupivacaine—Hypotension—Doxorubicin—urinary bladder cancer	0.000267	0.00043	CcSEcCtD
Bupivacaine—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	0.000266	0.00043	CcSEcCtD
Bupivacaine—Constipation—Epirubicin—urinary bladder cancer	0.000264	0.000425	CcSEcCtD
Bupivacaine—Pain—Epirubicin—urinary bladder cancer	0.000264	0.000425	CcSEcCtD
Bupivacaine—CYP2D6—Biological oxidations—HPGDS—urinary bladder cancer	0.000263	0.00185	CbGpPWpGaD
Bupivacaine—Urticaria—Methotrexate—urinary bladder cancer	0.000262	0.000422	CcSEcCtD
Bupivacaine—Body temperature increased—Methotrexate—urinary bladder cancer	0.000261	0.00042	CcSEcCtD
Bupivacaine—Abdominal pain—Methotrexate—urinary bladder cancer	0.000261	0.00042	CcSEcCtD
Bupivacaine—SCN4A—Developmental Biology—CDK4—urinary bladder cancer	0.000261	0.00183	CbGpPWpGaD
Bupivacaine—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	0.00026	0.000419	CcSEcCtD
Bupivacaine—Insomnia—Doxorubicin—urinary bladder cancer	0.000258	0.000416	CcSEcCtD
Bupivacaine—SCN10A—Axon guidance—ERBB2—urinary bladder cancer	0.000257	0.00181	CbGpPWpGaD
Bupivacaine—Paraesthesia—Doxorubicin—urinary bladder cancer	0.000256	0.000413	CcSEcCtD
Bupivacaine—CYP1A2—Phase II conjugation—GSTP1—urinary bladder cancer	0.000256	0.0018	CbGpPWpGaD
Bupivacaine—CYP2D6—Biological oxidations—GSTT1—urinary bladder cancer	0.000255	0.00179	CbGpPWpGaD
Bupivacaine—Dyspnoea—Doxorubicin—urinary bladder cancer	0.000255	0.00041	CcSEcCtD
Bupivacaine—Feeling abnormal—Epirubicin—urinary bladder cancer	0.000254	0.00041	CcSEcCtD
Bupivacaine—Somnolence—Doxorubicin—urinary bladder cancer	0.000254	0.000409	CcSEcCtD
Bupivacaine—Gastrointestinal pain—Epirubicin—urinary bladder cancer	0.000252	0.000407	CcSEcCtD
Bupivacaine—Dyspepsia—Doxorubicin—urinary bladder cancer	0.000251	0.000405	CcSEcCtD
Bupivacaine—SCN10A—Developmental Biology—CDK4—urinary bladder cancer	0.000251	0.00177	CbGpPWpGaD
Bupivacaine—Decreased appetite—Doxorubicin—urinary bladder cancer	0.000248	0.0004	CcSEcCtD
Bupivacaine—PTGER1—Class A/1 (Rhodopsin-like receptors)—CXCL8—urinary bladder cancer	0.000247	0.00173	CbGpPWpGaD
Bupivacaine—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	0.000246	0.000397	CcSEcCtD
Bupivacaine—Urticaria—Epirubicin—urinary bladder cancer	0.000245	0.000395	CcSEcCtD
Bupivacaine—Pain—Doxorubicin—urinary bladder cancer	0.000244	0.000394	CcSEcCtD
Bupivacaine—Constipation—Doxorubicin—urinary bladder cancer	0.000244	0.000394	CcSEcCtD
Bupivacaine—Abdominal pain—Epirubicin—urinary bladder cancer	0.000244	0.000393	CcSEcCtD
Bupivacaine—Body temperature increased—Epirubicin—urinary bladder cancer	0.000244	0.000393	CcSEcCtD
Bupivacaine—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—urinary bladder cancer	0.000243	0.00171	CbGpPWpGaD
Bupivacaine—Hypersensitivity—Methotrexate—urinary bladder cancer	0.000243	0.000392	CcSEcCtD
Bupivacaine—SCN4A—Developmental Biology—PPARG—urinary bladder cancer	0.000237	0.00166	CbGpPWpGaD
Bupivacaine—Asthenia—Methotrexate—urinary bladder cancer	0.000237	0.000381	CcSEcCtD
Bupivacaine—Feeling abnormal—Doxorubicin—urinary bladder cancer	0.000235	0.000379	CcSEcCtD
Bupivacaine—CYP1A2—Phase II conjugation—GSTM1—urinary bladder cancer	0.000235	0.00165	CbGpPWpGaD
Bupivacaine—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	0.000233	0.000376	CcSEcCtD
Bupivacaine—Pruritus—Methotrexate—urinary bladder cancer	0.000233	0.000376	CcSEcCtD
Bupivacaine—PTGER1—Signaling Pathways—GLI1—urinary bladder cancer	0.000233	0.00164	CbGpPWpGaD
Bupivacaine—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—urinary bladder cancer	0.00023	0.00162	CbGpPWpGaD
Bupivacaine—SCN4A—Axon guidance—MMP9—urinary bladder cancer	0.000229	0.00161	CbGpPWpGaD
Bupivacaine—SCN10A—Developmental Biology—PPARG—urinary bladder cancer	0.000228	0.00161	CbGpPWpGaD
Bupivacaine—SCN4A—Developmental Biology—CREBBP—urinary bladder cancer	0.000227	0.0016	CbGpPWpGaD
Bupivacaine—Hypersensitivity—Epirubicin—urinary bladder cancer	0.000227	0.000367	CcSEcCtD
Bupivacaine—Urticaria—Doxorubicin—urinary bladder cancer	0.000227	0.000366	CcSEcCtD
Bupivacaine—Body temperature increased—Doxorubicin—urinary bladder cancer	0.000226	0.000364	CcSEcCtD
Bupivacaine—Abdominal pain—Doxorubicin—urinary bladder cancer	0.000226	0.000364	CcSEcCtD
Bupivacaine—Diarrhoea—Methotrexate—urinary bladder cancer	0.000226	0.000364	CcSEcCtD
Bupivacaine—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—urinary bladder cancer	0.000222	0.00156	CbGpPWpGaD
Bupivacaine—CYP1A2—Biological oxidations—HPGDS—urinary bladder cancer	0.000222	0.00156	CbGpPWpGaD
Bupivacaine—Asthenia—Epirubicin—urinary bladder cancer	0.000221	0.000357	CcSEcCtD
Bupivacaine—SCN10A—Axon guidance—MMP9—urinary bladder cancer	0.000221	0.00155	CbGpPWpGaD
Bupivacaine—SCN10A—Developmental Biology—CREBBP—urinary bladder cancer	0.000219	0.00154	CbGpPWpGaD
Bupivacaine—Pruritus—Epirubicin—urinary bladder cancer	0.000218	0.000352	CcSEcCtD
Bupivacaine—Dizziness—Methotrexate—urinary bladder cancer	0.000218	0.000352	CcSEcCtD
Bupivacaine—CYP1A2—Biological oxidations—GSTT1—urinary bladder cancer	0.000216	0.00152	CbGpPWpGaD
Bupivacaine—CYP3A4—Biological oxidations—NAT2—urinary bladder cancer	0.000215	0.00151	CbGpPWpGaD
Bupivacaine—CYP3A4—Metapathway biotransformation—NAT2—urinary bladder cancer	0.000212	0.00149	CbGpPWpGaD
Bupivacaine—Diarrhoea—Epirubicin—urinary bladder cancer	0.000211	0.00034	CcSEcCtD
Bupivacaine—SCN4A—Axon guidance—SRC—urinary bladder cancer	0.000211	0.00148	CbGpPWpGaD
Bupivacaine—Hypersensitivity—Doxorubicin—urinary bladder cancer	0.00021	0.000339	CcSEcCtD
Bupivacaine—Vomiting—Methotrexate—urinary bladder cancer	0.00021	0.000338	CcSEcCtD
Bupivacaine—CYP1A2—Arachidonic acid metabolism—PTGS2—urinary bladder cancer	0.000208	0.00146	CbGpPWpGaD
Bupivacaine—Headache—Methotrexate—urinary bladder cancer	0.000207	0.000333	CcSEcCtD
Bupivacaine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—urinary bladder cancer	0.000206	0.00145	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism of lipids and lipoproteins—CYP4B1—urinary bladder cancer	0.000206	0.00145	CbGpPWpGaD
Bupivacaine—SCN4A—Developmental Biology—RHOA—urinary bladder cancer	0.000206	0.00145	CbGpPWpGaD
Bupivacaine—Asthenia—Doxorubicin—urinary bladder cancer	0.000205	0.00033	CcSEcCtD
Bupivacaine—Dizziness—Epirubicin—urinary bladder cancer	0.000204	0.000329	CcSEcCtD
Bupivacaine—SCN10A—Axon guidance—SRC—urinary bladder cancer	0.000204	0.00143	CbGpPWpGaD
Bupivacaine—Pruritus—Doxorubicin—urinary bladder cancer	0.000202	0.000326	CcSEcCtD
Bupivacaine—SCN10A—Developmental Biology—RHOA—urinary bladder cancer	0.000198	0.0014	CbGpPWpGaD
Bupivacaine—Vomiting—Epirubicin—urinary bladder cancer	0.000196	0.000316	CcSEcCtD
Bupivacaine—Nausea—Methotrexate—urinary bladder cancer	0.000196	0.000316	CcSEcCtD
Bupivacaine—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—urinary bladder cancer	0.000195	0.00137	CbGpPWpGaD
Bupivacaine—Diarrhoea—Doxorubicin—urinary bladder cancer	0.000195	0.000315	CcSEcCtD
Bupivacaine—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1A—urinary bladder cancer	0.000194	0.00137	CbGpPWpGaD
Bupivacaine—Headache—Epirubicin—urinary bladder cancer	0.000193	0.000312	CcSEcCtD
Bupivacaine—CYP2C19—Biological oxidations—GSTP1—urinary bladder cancer	0.000192	0.00135	CbGpPWpGaD
Bupivacaine—SCN4A—Developmental Biology—ERBB2—urinary bladder cancer	0.00019	0.00134	CbGpPWpGaD
Bupivacaine—CYP2C19—Metapathway biotransformation—GSTP1—urinary bladder cancer	0.000189	0.00133	CbGpPWpGaD
Bupivacaine—Dizziness—Doxorubicin—urinary bladder cancer	0.000189	0.000304	CcSEcCtD
Bupivacaine—PTGER1—GPCR ligand binding—CXCL8—urinary bladder cancer	0.000188	0.00132	CbGpPWpGaD
Bupivacaine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—urinary bladder cancer	0.000185	0.0013	CbGpPWpGaD
Bupivacaine—CYP1A2—Aryl Hydrocarbon Receptor—EP300—urinary bladder cancer	0.000185	0.0013	CbGpPWpGaD
Bupivacaine—SCN4A—Axon guidance—EGFR—urinary bladder cancer	0.000185	0.0013	CbGpPWpGaD
Bupivacaine—SCN10A—Developmental Biology—ERBB2—urinary bladder cancer	0.000184	0.00129	CbGpPWpGaD
Bupivacaine—Nausea—Epirubicin—urinary bladder cancer	0.000183	0.000296	CcSEcCtD
Bupivacaine—Vomiting—Doxorubicin—urinary bladder cancer	0.000182	0.000293	CcSEcCtD
Bupivacaine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—SRC—urinary bladder cancer	0.00018	0.00127	CbGpPWpGaD
Bupivacaine—CYP1A2—Aryl Hydrocarbon Receptor—SRC—urinary bladder cancer	0.00018	0.00127	CbGpPWpGaD
Bupivacaine—Headache—Doxorubicin—urinary bladder cancer	0.000179	0.000288	CcSEcCtD
Bupivacaine—SCN10A—Axon guidance—EGFR—urinary bladder cancer	0.000178	0.00125	CbGpPWpGaD
Bupivacaine—CYP2D6—Biological oxidations—GSTP1—urinary bladder cancer	0.000176	0.00124	CbGpPWpGaD
Bupivacaine—CYP2C19—Biological oxidations—GSTM1—urinary bladder cancer	0.000176	0.00124	CbGpPWpGaD
Bupivacaine—SCN4A—Axon guidance—KRAS—urinary bladder cancer	0.000175	0.00123	CbGpPWpGaD
Bupivacaine—CYP2D6—Metapathway biotransformation—GSTP1—urinary bladder cancer	0.000174	0.00122	CbGpPWpGaD
Bupivacaine—CYP2C19—Metapathway biotransformation—GSTM1—urinary bladder cancer	0.000174	0.00122	CbGpPWpGaD
Bupivacaine—CYP3A4—Biological oxidations—HPGDS—urinary bladder cancer	0.000172	0.00121	CbGpPWpGaD
Bupivacaine—Nausea—Doxorubicin—urinary bladder cancer	0.00017	0.000273	CcSEcCtD
Bupivacaine—SCN10A—Axon guidance—KRAS—urinary bladder cancer	0.000169	0.00119	CbGpPWpGaD
Bupivacaine—CYP3A4—Biological oxidations—GSTT1—urinary bladder cancer	0.000166	0.00117	CbGpPWpGaD
Bupivacaine—SCN4A—Developmental Biology—MMP9—urinary bladder cancer	0.000163	0.00115	CbGpPWpGaD
Bupivacaine—CYP2D6—Biological oxidations—GSTM1—urinary bladder cancer	0.000162	0.00114	CbGpPWpGaD
Bupivacaine—CYP1A2—Aryl Hydrocarbon Receptor—MYC—urinary bladder cancer	0.000161	0.00113	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—CYP4B1—urinary bladder cancer	0.000161	0.00113	CbGpPWpGaD
Bupivacaine—CYP2D6—Metapathway biotransformation—GSTM1—urinary bladder cancer	0.00016	0.00113	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—RBX1—urinary bladder cancer	0.00016	0.00112	CbGpPWpGaD
Bupivacaine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—urinary bladder cancer	0.000158	0.00111	CbGpPWpGaD
Bupivacaine—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—urinary bladder cancer	0.000158	0.00111	CbGpPWpGaD
Bupivacaine—SCN10A—Developmental Biology—MMP9—urinary bladder cancer	0.000158	0.00111	CbGpPWpGaD
Bupivacaine—SCN4A—Developmental Biology—EP300—urinary bladder cancer	0.000155	0.00109	CbGpPWpGaD
Bupivacaine—SCN4A—Developmental Biology—SRC—urinary bladder cancer	0.000151	0.00106	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—TSC1—urinary bladder cancer	0.00015	0.00106	CbGpPWpGaD
Bupivacaine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—urinary bladder cancer	0.00015	0.00106	CbGpPWpGaD
Bupivacaine—CYP1A2—Aryl Hydrocarbon Receptor—TNF—urinary bladder cancer	0.00015	0.00106	CbGpPWpGaD
Bupivacaine—CYP1A2—Biological oxidations—GSTP1—urinary bladder cancer	0.00015	0.00105	CbGpPWpGaD
Bupivacaine—SCN10A—Developmental Biology—EP300—urinary bladder cancer	0.000149	0.00105	CbGpPWpGaD
Bupivacaine—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—urinary bladder cancer	0.000149	0.00105	CbGpPWpGaD
Bupivacaine—SCN4A—Axon guidance—HRAS—urinary bladder cancer	0.000149	0.00104	CbGpPWpGaD
Bupivacaine—CYP1A2—Metapathway biotransformation—GSTP1—urinary bladder cancer	0.000147	0.00104	CbGpPWpGaD
Bupivacaine—SCN10A—Developmental Biology—SRC—urinary bladder cancer	0.000145	0.00102	CbGpPWpGaD
Bupivacaine—SCN10A—Axon guidance—HRAS—urinary bladder cancer	0.000143	0.00101	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—JAG1—urinary bladder cancer	0.000143	0.00101	CbGpPWpGaD
Bupivacaine—CYP1A2—Biological oxidations—GSTM1—urinary bladder cancer	0.000137	0.000966	CbGpPWpGaD
Bupivacaine—CYP1A2—Metapathway biotransformation—GSTM1—urinary bladder cancer	0.000135	0.000953	CbGpPWpGaD
Bupivacaine—SCN4A—Developmental Biology—EGFR—urinary bladder cancer	0.000132	0.000928	CbGpPWpGaD
Bupivacaine—SCN10A—Developmental Biology—EGFR—urinary bladder cancer	0.000127	0.000895	CbGpPWpGaD
Bupivacaine—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—urinary bladder cancer	0.000127	0.000891	CbGpPWpGaD
Bupivacaine—SCN4A—Developmental Biology—TNF—urinary bladder cancer	0.000126	0.000884	CbGpPWpGaD
Bupivacaine—SCN4A—Developmental Biology—KRAS—urinary bladder cancer	0.000125	0.000877	CbGpPWpGaD
Bupivacaine—SCN10A—Developmental Biology—TNF—urinary bladder cancer	0.000121	0.000853	CbGpPWpGaD
Bupivacaine—PTGER1—GPCR downstream signaling—RHOA—urinary bladder cancer	0.000121	0.00085	CbGpPWpGaD
Bupivacaine—SCN10A—Developmental Biology—KRAS—urinary bladder cancer	0.00012	0.000846	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—GSTZ1—urinary bladder cancer	0.000118	0.000827	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—S100B—urinary bladder cancer	0.000116	0.000815	CbGpPWpGaD
Bupivacaine—CYP3A4—Biological oxidations—GSTP1—urinary bladder cancer	0.000115	0.000812	CbGpPWpGaD
Bupivacaine—CYP3A4—Metapathway biotransformation—GSTP1—urinary bladder cancer	0.000114	0.0008	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—GSTO2—urinary bladder cancer	0.000111	0.000784	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—NAT1—urinary bladder cancer	0.000111	0.000784	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling by GPCR—RHOA—urinary bladder cancer	0.00011	0.000772	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	0.00011	0.000771	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—GSTZ1—urinary bladder cancer	0.000108	0.00076	CbGpPWpGaD
Bupivacaine—PTGER1—GPCR downstream signaling—CXCL8—urinary bladder cancer	0.000106	0.000747	CbGpPWpGaD
Bupivacaine—CYP3A4—Biological oxidations—GSTM1—urinary bladder cancer	0.000106	0.000746	CbGpPWpGaD
Bupivacaine—SCN4A—Developmental Biology—HRAS—urinary bladder cancer	0.000106	0.000746	CbGpPWpGaD
Bupivacaine—CYP3A4—Metapathway biotransformation—GSTM1—urinary bladder cancer	0.000105	0.000736	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—NCOR1—urinary bladder cancer	0.000104	0.000732	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—GSTO2—urinary bladder cancer	0.000102	0.000721	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—NAT1—urinary bladder cancer	0.000102	0.000721	CbGpPWpGaD
Bupivacaine—SCN10A—Developmental Biology—HRAS—urinary bladder cancer	0.000102	0.000719	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—UGT2B7—urinary bladder cancer	0.000102	0.000717	CbGpPWpGaD
Bupivacaine—PTGER1—GPCR downstream signaling—IL2—urinary bladder cancer	0.000101	0.000713	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling by GPCR—CXCL8—urinary bladder cancer	9.64e-05	0.000678	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—UGT2B7—urinary bladder cancer	9.37e-05	0.000659	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling by GPCR—IL2—urinary bladder cancer	9.21e-05	0.000648	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—TERT—urinary bladder cancer	9.18e-05	0.000646	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—CYP4B1—urinary bladder cancer	9.18e-05	0.000645	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—GSTZ1—urinary bladder cancer	9.16e-05	0.000644	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—GSTO2—urinary bladder cancer	8.68e-05	0.000611	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—NAT1—urinary bladder cancer	8.68e-05	0.000611	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—SLC19A1—urinary bladder cancer	8.67e-05	0.00061	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	8.54e-05	0.000601	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—PRSS3—urinary bladder cancer	8.44e-05	0.000594	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—CYP4B1—urinary bladder cancer	8.44e-05	0.000594	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—FGFR3—urinary bladder cancer	8.42e-05	0.000592	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—ESR1—urinary bladder cancer	8.18e-05	0.000575	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—SLC19A1—urinary bladder cancer	7.97e-05	0.000561	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—UGT2B7—urinary bladder cancer	7.94e-05	0.000559	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—PRSS3—urinary bladder cancer	7.77e-05	0.000546	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—CREBBP—urinary bladder cancer	7.17e-05	0.000504	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—CYP4B1—urinary bladder cancer	7.15e-05	0.000503	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—IGF1—urinary bladder cancer	7.08e-05	0.000498	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—GSTZ1—urinary bladder cancer	7.07e-05	0.000497	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling by GPCR—EGFR—urinary bladder cancer	7.04e-05	0.000496	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	6.77e-05	0.000476	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—SLC19A1—urinary bladder cancer	6.75e-05	0.000475	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—TYMP—urinary bladder cancer	6.75e-05	0.000475	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—NAT1—urinary bladder cancer	6.7e-05	0.000471	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—GSTO2—urinary bladder cancer	6.7e-05	0.000471	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling by GPCR—KRAS—urinary bladder cancer	6.66e-05	0.000468	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—PRSS3—urinary bladder cancer	6.58e-05	0.000463	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—RHOA—urinary bladder cancer	6.49e-05	0.000456	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	6.48e-05	0.000456	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—TYMP—urinary bladder cancer	6.21e-05	0.000437	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—UGT2B7—urinary bladder cancer	6.13e-05	0.000431	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—NAT2—urinary bladder cancer	6.11e-05	0.000429	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—ERBB2—urinary bladder cancer	6e-05	0.000422	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—CXCL8—urinary bladder cancer	5.69e-05	0.0004	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling by GPCR—HRAS—urinary bladder cancer	5.66e-05	0.000398	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—NAT2—urinary bladder cancer	5.62e-05	0.000395	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—CYP4B1—urinary bladder cancer	5.52e-05	0.000388	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—IL2—urinary bladder cancer	5.44e-05	0.000383	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—CCND1—urinary bladder cancer	5.3e-05	0.000373	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	5.28e-05	0.000371	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—RRM2—urinary bladder cancer	5.27e-05	0.000371	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—TYMP—urinary bladder cancer	5.26e-05	0.00037	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—SLC19A1—urinary bladder cancer	5.21e-05	0.000367	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—MMP9—urinary bladder cancer	5.15e-05	0.000362	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—CDKN1A—urinary bladder cancer	5.13e-05	0.000361	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—PTEN—urinary bladder cancer	5.12e-05	0.00036	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—PRSS3—urinary bladder cancer	5.08e-05	0.000357	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	5.05e-05	0.000355	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—EP300—urinary bladder cancer	4.88e-05	0.000343	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—HPGDS—urinary bladder cancer	4.88e-05	0.000343	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—ENO2—urinary bladder cancer	4.88e-05	0.000343	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	4.85e-05	0.000341	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—RRM2—urinary bladder cancer	4.85e-05	0.000341	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—NAT2—urinary bladder cancer	4.76e-05	0.000335	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—SRC—urinary bladder cancer	4.75e-05	0.000334	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—GSTT1—urinary bladder cancer	4.73e-05	0.000333	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	4.66e-05	0.000328	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—HPGDS—urinary bladder cancer	4.49e-05	0.000316	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—ENO2—urinary bladder cancer	4.49e-05	0.000316	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—GSTT1—urinary bladder cancer	4.35e-05	0.000306	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—MYC—urinary bladder cancer	4.25e-05	0.000299	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—EGFR—urinary bladder cancer	4.16e-05	0.000293	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—RRM2—urinary bladder cancer	4.11e-05	0.000289	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—TYMP—urinary bladder cancer	4.06e-05	0.000286	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—NQO1—urinary bladder cancer	3.93e-05	0.000277	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—KRAS—urinary bladder cancer	3.93e-05	0.000277	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	3.82e-05	0.000268	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—ENO2—urinary bladder cancer	3.8e-05	0.000267	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—HPGDS—urinary bladder cancer	3.8e-05	0.000267	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	3.78e-05	0.000266	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—GSTT1—urinary bladder cancer	3.69e-05	0.000259	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—NAT2—urinary bladder cancer	3.67e-05	0.000258	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	3.63e-05	0.000255	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—NQO1—urinary bladder cancer	3.62e-05	0.000255	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—TP53—urinary bladder cancer	3.49e-05	0.000246	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—HRAS—urinary bladder cancer	3.34e-05	0.000235	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	3.33e-05	0.000234	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—GSTP1—urinary bladder cancer	3.28e-05	0.000231	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	3.17e-05	0.000223	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—RRM2—urinary bladder cancer	3.17e-05	0.000223	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—NQO1—urinary bladder cancer	3.07e-05	0.000216	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—TYMS—urinary bladder cancer	3.05e-05	0.000215	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—GSTP1—urinary bladder cancer	3.02e-05	0.000212	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—GSTM1—urinary bladder cancer	3.02e-05	0.000212	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—NCOR1—urinary bladder cancer	3.02e-05	0.000212	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	2.97e-05	0.000209	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—ENO2—urinary bladder cancer	2.94e-05	0.000206	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—HPGDS—urinary bladder cancer	2.94e-05	0.000206	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—GPX1—urinary bladder cancer	2.89e-05	0.000203	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—GSTT1—urinary bladder cancer	2.85e-05	0.0002	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—ERCC2—urinary bladder cancer	2.84e-05	0.000199	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—TYMS—urinary bladder cancer	2.81e-05	0.000197	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—GSTM1—urinary bladder cancer	2.77e-05	0.000195	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—NCOR1—urinary bladder cancer	2.77e-05	0.000195	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—MTHFR—urinary bladder cancer	2.66e-05	0.000187	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—GPX1—urinary bladder cancer	2.66e-05	0.000187	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—ERCC2—urinary bladder cancer	2.61e-05	0.000183	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	2.59e-05	0.000182	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—GSTP1—urinary bladder cancer	2.56e-05	0.00018	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	2.47e-05	0.000174	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—MTHFR—urinary bladder cancer	2.45e-05	0.000172	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—TYMS—urinary bladder cancer	2.38e-05	0.000167	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—NQO1—urinary bladder cancer	2.37e-05	0.000166	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—GSTM1—urinary bladder cancer	2.35e-05	0.000165	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—NCOR1—urinary bladder cancer	2.35e-05	0.000165	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—GPX1—urinary bladder cancer	2.25e-05	0.000158	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—ERCC2—urinary bladder cancer	2.21e-05	0.000155	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—PPARG—urinary bladder cancer	2.16e-05	0.000152	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—MTHFR—urinary bladder cancer	2.08e-05	0.000146	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—CREBBP—urinary bladder cancer	2.08e-05	0.000146	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—PPARG—urinary bladder cancer	1.99e-05	0.00014	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—GSTP1—urinary bladder cancer	1.97e-05	0.000139	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—CREBBP—urinary bladder cancer	1.91e-05	0.000134	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—TYMS—urinary bladder cancer	1.83e-05	0.000129	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—NCOR1—urinary bladder cancer	1.81e-05	0.000128	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—GSTM1—urinary bladder cancer	1.81e-05	0.000128	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—GPX1—urinary bladder cancer	1.74e-05	0.000122	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—ERCC2—urinary bladder cancer	1.7e-05	0.00012	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—PTGS2—urinary bladder cancer	1.7e-05	0.00012	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—PPARG—urinary bladder cancer	1.68e-05	0.000118	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—CREBBP—urinary bladder cancer	1.62e-05	0.000114	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—MTHFR—urinary bladder cancer	1.6e-05	0.000113	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—PTGS2—urinary bladder cancer	1.56e-05	0.00011	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—PTEN—urinary bladder cancer	1.48e-05	0.000104	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—EP300—urinary bladder cancer	1.41e-05	9.94e-05	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—PTEN—urinary bladder cancer	1.36e-05	9.59e-05	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—PTGS2—urinary bladder cancer	1.32e-05	9.32e-05	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—EP300—urinary bladder cancer	1.3e-05	9.15e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—PPARG—urinary bladder cancer	1.3e-05	9.14e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—CREBBP—urinary bladder cancer	1.25e-05	8.78e-05	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—PTEN—urinary bladder cancer	1.16e-05	8.13e-05	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—EP300—urinary bladder cancer	1.1e-05	7.75e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—PTGS2—urinary bladder cancer	1.02e-05	7.19e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—PTEN—urinary bladder cancer	8.92e-06	6.27e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—EP300—urinary bladder cancer	8.5e-06	5.98e-05	CbGpPWpGaD
